FDA Inspection
Jiangsu Hengrui Pharmaceuticals Co., Ltd.Jiangsu Hengrui Pharmaceuticals Co., Ltd. – FDA Inspection, Apr 4, 2025
Record Details
This FDA Inspection record concerns Jiangsu Hengrui Pharmaceuticals Co., Ltd., with an inspection on April 4, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 45baa0c0-8a4e-43c4-9343-d01f00fa5358
Inspection Facts
- Inspection number
- 1266877
- FDA center
- Human Drugs
Other FDA inspections of Jiangsu Hengrui Pharmaceuticals Co., Ltd.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 19, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 2, 2023 | Not classified | Office of Inspections and Investigations |
Other documents for Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- FDA Inspection 1233962 - 2024-01-19
- FDA Inspection 1209987 - 2023-06-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.